Camilla Björn
Forskare
Tel
Email
Location
Göteborg
ORCID
![](https://www.ri.se/sites/default/files/styles/profile_single/public/2018/10/Camilla-Bjorn.jpg.webp)
Camilla is the leader of the focus area Infection Management within the business and innovation area Health and Life Science.
She works as a researcher and project manager within the pharmaceutical and especially the medical device field with a specific focus on antibiotics, antimicrobial substances/materials, antibiotic resistance, infection prevention, hygiene, etc. She holds a master's degree in biotechnology and a PhD in medicine.
Ask me about
Publications
Ask me about
Publications
- Can particle counting replace conventional surveillance for airborne bacterial …
- Characterization and Antibacterial Properties of Autoclaved Carboxylated Wood N…
- Antimicrobial peptides as therapeutic agents : opportunities and challenges.
- Antibiotic-Free Cationic Dendritic Hydrogels as Surgical-Site-Infection-Inhibit…
- Characterization of the <i>in vitro, ex vivo</i>, and <i>in vivo</i> Efficacy o…
- Antimicrobial peptides in the treatment of infectious and inflammatory conditio…
- Antimicrobial peptides : An emerging category of therapeutic agents
- Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r
- Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mous…
- Efficacy of the novel topical antimicrobial agent pxl150 in a mouse model of su…